Trends in mortality of diffuse malignant mesothelioma of pleura

Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2013

Mycobacterium tuberculosis induces CCL18 expression in human macrophages.

Scandinavian journal of immunology·2008

Prevalence of workplace exacerbation of asthma symptoms in an urban working population of asthmatics.

Journal of occupational and environmental medicine·2006

Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.

Cancer gene therapy·2006

Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression.

Gene therapy·2005

Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997.

Chest·2001

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Linvoseltamab outcomes by frailty status in patients with relapsed/refractory multiple myeloma: a subgroup analysis of the LINKER-MM1 study.

Blood cancer journal·2026

Relapse and disability across the disease course of MOGAD: a real-world cohort study from northern China.

Multiple sclerosis and related disorders·2026

Recurrent giant retroperitoneal liposarcoma: A case report.

Medicine·2026

Nationwide Surveillance and Control Measures during Large Measles Outbreak, Bangladesh, 2026.

Emerging infectious diseases·2026

Candida lusitaniae as an Unusual Cause of Otomycosis: A Case Report and Literature Review.

Cureus·2026

Spectrometric Assessment of Intralot and Interlot Variability in Mycophenolate Mofetil for Injection Using Near-Infrared Spectrometry and Nonparametric Subcluster Detection.

Contact in context·2026

Related Experiment Videos

Trends in mortality of diffuse malignant mesothelioma of pleura

Related Concept Videos

Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis.

Mycobacterium tuberculosis induces CCL18 expression in human macrophages.

Prevalence of workplace exacerbation of asthma symptoms in an urban working population of asthmatics.

Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.

Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression.

Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Linvoseltamab outcomes by frailty status in patients with relapsed/refractory multiple myeloma: a subgroup analysis of the LINKER-MM1 study.

Relapse and disability across the disease course of MOGAD: a real-world cohort study from northern China.

Recurrent giant retroperitoneal liposarcoma: A case report.

Nationwide Surveillance and Control Measures during Large Measles Outbreak, Bangladesh, 2026.

Candida lusitaniae as an Unusual Cause of Otomycosis: A Case Report and Literature Review.

Spectrometric Assessment of Intralot and Interlot Variability in Mycophenolate Mofetil for Injection Using Near-Infrared Spectrometry and Nonparametric Subcluster Detection.

Related Experiment Videos

Trends in mortality of diffuse malignant mesothelioma of pleura

Related Concept Videos

Related Articles